National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 47755-47756 [2017-22142]
Download as PDF
Federal Register / Vol. 82, No. 197 / Friday, October 13, 2017 / Notices
Contact Person: Angela Y Ng, Ph.D., MBA,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6200,
MSC 7804, Bethesda, MD 20892, 301–435–
1715, nga@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Pregnancy,
Placentation, and Neonatology.
Date: November 9, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Gary Hunnicutt, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164,
MSC 7892, Bethesda, MD 20892, 301–435–
0229, gary.hunnicutt@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 6, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–22139 Filed 10–12–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
patent applications listed below may be
obtained by emailing the indicated
licensing contact at the National Heart,
Lung, and Blood, Office of Technology
Transfer and Development Office of
Technology Transfer, 31 Center Drive
Room 4A29, MSC2479, Bethesda, MD
20892–2479; telephone: 301–402–5579.
A signed Confidential Disclosure
Agreement may be required to receive
copies of the patent applications.
SUPPLEMENTARY INFORMATION: This
notice is in accordance with 35 U.S.C.
209 and 37 CFR part 404 to achieve
commercialization of results of
federally-funded research and
development. Foreign patent
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:05 Oct 12, 2017
Jkt 244001
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing. A description of the
technology follows.
Small Interfering RNA Inhibition of
Cannabanoid-1 Receptor (CB1R) for
Treating Type 2 Diabetes
Description of Technology: The
invention pertains to the use of glucan
encapsulated non-immunostimulatory
small interfering RNAs (siRNAs) to treat
type-2 diabetes. Endocannabinoids (EC)
are lipid signaling molecules that act on
the same cannabinoid receptors that
recognize and mediate the effects of
endo- and phytocannabanoids. EC
receptor CB1R activation is implicated
in the development of obesity and its
metabolic consequences, including
insulin resistance and type 2 diabetes.
Beta-cell loss has been demonstrated in
a Zucker diabetic fatty (ZDF) rat model
of type-2 diabetes through CB1Rmediated activation of a macrophagemediated inflammatory response.
Conversely, rats treated with a
peripheral CB1R antagonist restores
normoglycemia and preserves beta-cell
function. Similar results are seen
following selective in vivo knockdown
of macrophage CB1R by daily treatment
of ZDF rats with the instant D-glucanencapsulated CB1R Small interfering
RNA (siRNA). Knock-down of CB1R
with using glucan encapsulated siRNA
may represent a new commecializable
method of treating type-2 diabetes or
preventing the progression of insulin
resistance to overt diabetes.
Potential Commercial Applications:
Treatment of obesity, insulin resistance,
and diabetes.
Development Stage: In vivo data
available.
Inventors: George Kunos, Tony
Jourdan (NIAAA), Michael Czech,
Myriam Aouadi.
Intellectual Property: HHS Reference
No. E–103–2013/0, U.S. Provisional
Patent Application 61/839,239 filed
June 25, 2013, International Patent
Application PCT/US2014/043924 filed
June 24, 2014, European Patent
Application 14818342.9 filed June 24,
2014 and U.S. Patent Application 14/
900,951 filed June 24, 2014.
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@nih.gov.
Dated: October 5, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development.
[FR Doc. 2017–22147 Filed 10–12–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
47755
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Neurological Sciences
Training Initial Review Group; NST–2
Subcommittee.
Date: October 23, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Crystal City, 2399 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Elizabeth Webber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–1917, Webbere@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; R13 Review.
Date: October 26, 2017.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ernie Lyons, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–4056, lyonse@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; F32 and K22 Review.
Date: November 2–3, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\13OCN1.SGM
13OCN1
47756
Federal Register / Vol. 82, No. 197 / Friday, October 13, 2017 / Notices
Place: The Westin Arlington Gateway, 801
N. Glebe Road, Arlington, VA 22203.
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–9223, Jimok.kim@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Stroke Clinical Trials.
Date: November 2, 2017.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street NW.,
Washington, DC 20037.
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; R13 Review.
Date: November 8, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ernie Lyons, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–4056, lyonse@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Jointly Sponsored T32
Review.
Date: December 7–8, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites by Hilton
Alexandria Old Town, 1900 Diagonal Road,
Alexandria, VA 22314.
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–9223, Jimok.kim@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: October 6, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
60 days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Specimen
Resource Locator, 0925–0703
Reinstatement without Change, National
Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The availability of
specimens and associated data is critical
to increase our knowledge of cancer
biology, and to translate important
research discoveries to clinical
application. The discovery and
validation of cancer prevention markers
require access, by researchers, to quality
clinical biospecimens. In response, to
this need, the National Cancer
Institute’s (NCI) Cancer Diagnosis
Program has developed, and is
expanding, a searchable database:
Specimen Resource Locator (SRL). The
SRL allows scientists in the research
community and the NCI to locate
specimens needed for their research.
The SRL will list all NCI supported
repositories and their links. This
administrative submission is an on-line
form that will collect information to
manage and improve a program and its
resources for the use of all scientists.
This submission does not involve any
analysis.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
105.
[FR Doc. 2017–22142 Filed 10–12–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Specimen
Resource Locator (NCI)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30 days of October 13, 2017.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to (202) 395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Joanne Demchok,
Program Director, Cancer Diagnosis
Program, Division of Cancer Treatment
and Diagnosis, 9609 Medical Center
Drive, Rockville, MD 20892 or call nontoll-free number (240) 276–5959 or
Email your request, including your
address to: peterjo@mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on July 28, 2017 and allowed
SUMMARY:
asabaliauskas on DSKBBXCHB2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Private Sector ..............................................................
State Government .......................................................
Federal Government ....................................................
Private Sector ..............................................................
Initial Request ........
VerDate Sep<11>2014
18:05 Oct 12, 2017
Jkt 244001
PO 00000
Annual Update .......
Frm 00070
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
70
70
60
20
E:\FR\FM\13OCN1.SGM
1
1
1
1
13OCN1
Average
burden per
response
(in hours)
30/60
30/60
30/60
5/60
Total
burden hours
35
35
30
2
Agencies
[Federal Register Volume 82, Number 197 (Friday, October 13, 2017)]
[Notices]
[Pages 47755-47756]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-22142]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Neurological Sciences Training Initial Review
Group; NST-2 Subcommittee.
Date: October 23, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Crystal City, 2399 Jefferson Davis Highway,
Arlington, VA 22202.
Contact Person: Elizabeth Webber, Ph.D., Scientific Review
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892-9529, (301) 496-1917, Webbere@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; R13 Review.
Date: October 26, 2017.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Ernie Lyons, Ph.D., Scientific Review Officer,
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529,
(301) 496-4056, lyonse@ninds.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; F32 and K22 Review.
Date: November 2-3, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 47756]]
Place: The Westin Arlington Gateway, 801 N. Glebe Road,
Arlington, VA 22203.
Contact Person: Jimok Kim, Ph.D., Scientific Review Officer,
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529,
(301) 496-9223, Jimok.kim@nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Stroke Clinical Trials.
Date: November 2, 2017.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Palomar, 2121 P Street NW., Washington, DC 20037.
Contact Person: Shanta Rajaram, Ph.D., Scientific Review
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892-9529, (301) 496-6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; R13 Review.
Date: November 8, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Ernie Lyons, Ph.D., Scientific Review Officer,
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529,
(301) 496-4056, lyonse@ninds.nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Jointly Sponsored T32 Review.
Date: December 7-8, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites by Hilton Alexandria Old Town, 1900
Diagonal Road, Alexandria, VA 22314.
Contact Person: Jimok Kim, Ph.D., Scientific Review Officer,
Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001
Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892-9529,
(301) 496-9223, Jimok.kim@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: October 6, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-22142 Filed 10-12-17; 8:45 am]
BILLING CODE 4140-01-P